4//SEC Filing
HAMER JOHN 4
Accession 0001209191-21-054543
CIK 0001703057other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 6:12 PM ET
Size
9.0 KB
Accession
0001209191-21-054543
Insider Transaction Report
Form 4
HAMER JOHN
Director10% Owner
Transactions
- Sale
Common Shares
2021-08-31$16.95/sh−162,649$2,756,901→ 266,213 total - Sale
Common Shares
2021-09-01$16.93/sh−137,351$2,325,352→ 128,862 total
Holdings
- 14,605,761(indirect: See footnote)
Common Shares
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.64 and $17.51. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Effective August 20, 2021, DCVC Bio GP, LLC ("DCVC Bio GP"), distributed 428,862 common shares of the Issuer to John Hamer in connection with a pro-rata distribution for no consideration to the members of DCVC Bio GP.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.56 and $17.38. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]These securities are held by DCVC Bio, L.P. ("DCVC Bio"). DCVC Bio GP is the general partner of DCVC Bio. JNK Capital Management, LLC ("JNK") and ZNM Capital Management, LLC ("ZNM") are the managing members of DCVC Bio GP. JNK and ZNM share voting and dispositive power with respect to the securities held by DCVC Bio. The Reporting Person is one of the managing members of JNK. The managing members of JNK and ZNM share voting and dispositive power with respect to the securities held by DCVC Bio. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that he is the beneficial owner of such securities, except to the extent of his indirect pecuniary interest therein, if any, by virtue of his interest in DCVC Bio GP and JNK, as applicable.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001198174
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 6:12 PM ET
- Size
- 9.0 KB